CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 2,600 enrolled
Drug / intervention
biodegradable polymer Rapamycin-eluting stent +2 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00598676
NCT00598676Phase 4Completed
CompareCT.gov

Intracoronary Stenting and Angiographic Results: Test Efficacy of 3 Limus-Eluting STents (ISAR-TEST 4): Prospective, Randomized Trial of 3-limus Agent-eluting Stents With Different Polymer Coatings

Deutsches Herzzentrum Muenchen·interventional·Posted Jan 22, 2008·Updated Mar 15, 2010

In Brief

A Phase 4 clinical trial evaluating biodegradable polymer Rapamycin-eluting stent, permanent polymer rapamycin-eluting stent (Cypher), and 1 other intervention for Coronary Heart Disease. Completed, enrolled 2,600 participants across 2 sites.

Detailed Summary

The aim of this study is to determine whether biodegradable polymer based rapamycin-eluting stent performs equal to permanent polymer based everolimus- and rapamycin-eluting stents regarding reduction of adverse cardiac events at one year.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCoronary Heart Disease
CountriesGermany
Collaborators--

Timeline

Phase 4CompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJan 22, 2008
Enrollment StartSep 1, 2007
Primary CompletionMar 1, 2009
Study CompletionApr 1, 2009
TodayJul 1, 2026
Enrollment to primary: 1.5 yearsPosted 18.4 years ago

Interventions

biodegradable polymer Rapamycin-eluting stentdevice

due to randomization, rapamycin-eluting stent with biodegradable polymer will be implanted

permanent polymer rapamycin-eluting stent (Cypher)device

due to randomization, rapamycin-eluting stent with permanent polymer will be implanted

permanent polymer everolimus-eluting stent (Xience, Promus)device

due to randomization, everolimus-eluting stent with permanent polymer will be implanted